Media Summary: In this week's installment of our “How Does It Work?” video series, we'll explore Chair, Jinsy A. Andrews, MD, MSc, FAAN, discusses amyotrophic lateral sclerosis in this CME activity titled “A Visual Exploration ... Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping.
Antisense Oligonucleotide Therapy - Detailed Analysis & Overview
In this week's installment of our “How Does It Work?” video series, we'll explore Chair, Jinsy A. Andrews, MD, MSc, FAAN, discusses amyotrophic lateral sclerosis in this CME activity titled “A Visual Exploration ... Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping. PUBLISHED 05/01/2019 In this episode Dr. Steve Perrin, CEO at the ALS Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals Anne Smith, PhD, is an Executive Director of ... Adrian Krainer is the St. Giles Foundation Professor at Cold Spring Harbor Laboratory. He received a B.A. cum laude in ...
Certara supported the first FDA approval of an For this week's episode of our “How Does It Work?” series, we dive further into exploring Presenter Biography …………… Robert MacLeod Dr. MacLeod is currently the Vice President Oncology Research and ... Retinitis pigmentosa (RP) is a degenerative eye disease that impacts about 100000 individuals in the U.S. Often diagnosed in ... Researcher Dr. Adrian Krainer explains the science behind Seattle Science Foundation is a non-profit organization dedicated to the international ...
After decades of research and development, synthetic nucleic acids are beginning to enjoy significant success in the clinic. In this video, Dr. Joseph Dougherty talks about what ASO ( Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of
